Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects
Clinical trial NCT05517486 · UNKNOWN
Trial details
- NCT number
- NCT05517486
- Sponsor
- Grace Therapeutics Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2022-08-21
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.